Microglial Phagocytosis and AB-Mediated Neurotoxicity
About the Research Project
Program
Award Type
Standard
Award Amount
$160,326
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000052
Summary
Microglia are specialized phagocytic cells of the central nervous system that engulf or phagocytize material and also mediate inflammatory responses. Based on these properties, they are thought to play a role in AD, especially since cell culture studies have shown that they can also phagocytize Ab. However, there is also some evidence that microglia do not effectively break down internalized Ab. This may lead to chronic activation and contribute to the progression of the disease. Dr. Webster is trying to determine whether the ingestion of Ab by brain cells causes the release of neurotoxic inflammatory molecules called cytokines. The production of oxygen-free radicals is also being monitored, and the production of both cytokines and free radicals will be correlated with the amount of undegraded Ab present inside the microglial cells. This information is important because some of the therapies currently being explored, such as an Ab vaccine, are predicated on the assumption that increased uptake of Ab by microglia will alleviate disease. However, if Ab activates microglia inflammatory responses, then the strategy of stimulating uptake could actually worsen the disease.
Related Grants
Alzheimer's Disease Research
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco
Alzheimer's Disease Research
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Alzheimer's Disease Research
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco